Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses

Dengue virus (DENV) is responsible for approximately 100 million cases of dengue fever annually, including severe forms such as hemorrhagic dengue and dengue shock syndrome. Despite intensive vaccine research and development spanning several decades, a universally accepted and approved vaccine again...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemirov, Kirill, Authié, Pierre, Souque, Philippe, Moncoq, Fanny, Noirat, Amandine, Blanc, Catherine, Bourgine, Maryline, Majlessi, Laleh, Charneau, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466046/
https://www.ncbi.nlm.nih.gov/pubmed/37654495
http://dx.doi.org/10.3389/fimmu.2023.1208041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466046/
https://www.ncbi.nlm.nih.gov/pubmed/37654495
http://dx.doi.org/10.3389/fimmu.2023.1208041

Ejemplares similares